Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.04
-0.11 (-1.20%)
Jan 22, 2025, 9:44 AM EST - Market open
Theravance Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 22, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 445 | 560 | 755 | 814 | 1,137 | 1,470 | |
| Market Cap Growth | -13.49% | -25.82% | -7.35% | -28.37% | -22.63% | 3.64% | |
| Enterprise Value | 404 | 477 | 320 | 1,269 | 1,398 | 1,620 | |
| Last Close Price | 9.15 | 11.24 | 11.22 | 11.05 | 17.77 | 25.89 | |
| PE Ratio | - | - | 0.87 | - | - | - | |
| PS Ratio | 7.07 | 9.75 | 14.70 | 14.72 | 15.82 | 20.02 | |
| PB Ratio | 2.42 | 2.63 | 1.71 | -2.41 | -3.74 | -6.57 | |
| P/TBV Ratio | 2.12 | 2.63 | 1.71 | - | - | - | |
| EV/Sales Ratio | 6.39 | 8.30 | 6.23 | 22.95 | 19.46 | 22.07 | |
| Debt / Equity Ratio | 0.24 | 0.23 | 0.12 | -1.98 | -2.23 | -2.28 | |
| Asset Turnover | 0.16 | 0.12 | 0.10 | 0.13 | 0.16 | 0.15 | |
| Quick Ratio | 4.62 | 4.84 | 11.99 | 3.20 | 2.93 | 2.97 | |
| Current Ratio | 4.97 | 5.39 | 12.31 | 4.26 | 3.18 | 3.03 | |
| Return on Equity (ROE) | -22.88% | -16.86% | -179.84% | - | - | - | |
| Return on Assets (ROA) | -6.41% | -6.73% | -10.07% | -35.20% | -42.38% | -32.49% | |
| Return on Capital (ROIC) | -9.35% | -8.81% | -11.99% | -42.23% | -56.44% | -45.67% | |
| Earnings Yield | -10.98% | -9.86% | 115.58% | -24.49% | -24.45% | -16.09% | |
| FCF Yield | -2.73% | -5.27% | -24.86% | -25.94% | -22.61% | -16.42% | |
| Buyback Yield / Dilution | 18.30% | 24.85% | -5.95% | -11.41% | -12.11% | -3.04% | |
| Total Shareholder Return | 18.30% | 24.85% | -5.95% | -11.41% | -12.11% | -3.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.